Regardless of case detection method, serology detected anti-CSP antibodies in 21% of the current infections (as detected by PCR; n = 14 samples) and in 6% of the non-infected individuals who reported a history of malaria in the last 6 months (n = 126 samples). This evidence concerns the gene DNAJC5 and malaria.